Skip to content
★ Sign in to follow
SP

S P Dingemans

GlaxoSmithKline plc
Total declarations
6
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 16 Apr 2019 for GlaxoSmithKline plc, €18.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

S P Dingemans: trading record in brief

All filings by S P Dingemans on record concern GlaxoSmithKline plc. We count 6 filings; the first trade dates from 12 October 2018 and the latest from 15 April 2019.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 16 April 2019 with a share grant (€18) in GlaxoSmithKline plc. Filings reach the RNS (LSE) feed a median of 4 days after the trade. For comparison, UK MAR gives managers three business days to notify a trade. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to S P Dingemans

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    Executive DirectorExecutivesGlaxoSmithKline plc
    16 GBP11FCA-NSM
    4,618.605 shares@ £15.660.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190416172302_14043633_20200326185042775_11222
  • ◆
    Executive DirectorExecutivesGlaxoSmithKline plc
    0 GBP11FCA-NSM
    0.001 shares@ £20.000.0% of flowLondon Stock Exchange (XLON)FCA-NSM:LSE20190416171422_14043624_20200326185042776_11229-3
  • ◆
    Chief Financial OfficerExecutivesGlaxoSmithKline plc
    16,060 GBP23FCA-NSM
    1,050.55 shares@ £15.287541.8% of flowLondon Stock Exchange (XLON)FCA-NSM:LSE20190115171501_13935643_20200326185116240_17223-2
  • ◆
    Chief Financial OfficerExecutivesGlaxoSmithKline plc
    22,380 GBP25FCA-NSM
    1,457 shares@ £15.3658.2% of flowLondon Stock Exchange (XLON)FCA-NSM:LSE20190115145624_13935423_20200326185116249_17425-2
  • ◆
    Chief Financial OfficerExecutivesGlaxoSmithKline plc
    15,854 GBP22FCA-NSM
    1,086.771 shares@ £14.587929.8% of flowLondon Stock Exchange (XLON)FCA-NSM:LSE20181016165353_13831182_20200330111443187_13744-2

5 of 5 declarations